Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 19, 2025
Evaluation of Nectin-4 and Trop-2: Implications for Patient Outcomes and Therapy in Penile Cancer
Jan Niklas Mink, Markus Eckstein, Oybek Khalmurzaev, et al.
Translational Oncology
|
November 13, 2021
DKK1 inhibits canonical Wnt signaling in human papillomavirus-positive penile cancer cells
Isabelle Ariane Bley, Anabel Zwick, Muriel Charlotte Hans, et al.
Frontiers in Oncology
|
October 28, 2022
The prominent role of the S100A8/S100A9-CD147 axis in the progression of penile cancer
Tobias Mohr, Anabel Zwick, Muriel Charlotte Hans, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 2, 2009
Human IgG2 antibodies against epidermal growth factor receptor effectively trigger antibody-dependent cellular cytotoxicity but, in contrast to IgG1, only by cells of myeloid lineage
Tanja Schneider-Merck, Jeroen J Lammerts van Bueren, Sven Berger, et al.
Cancer Research
|
December 5, 2015
An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In Vivo
Stefan Lohse, Saskia Meyer, Laura A P M Meulenbroek, et al.
Cancer Immunology Research
|
September 27, 2015
Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing
Arianne M Brandsma, Toine Ten Broeke, Maaike Nederend, et al.
Neoplasia (New York, N.Y.)
|
April 13, 2012
Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression
Stefanie Derer, Sven Berger, Martin Schlaeth, et al.
Plos One
|
September 2, 2022
Human papillomavirus vaccination of girls in the German model region Saarland: Insurance data-based analysis and identification of starting points for improving vaccination rates
Anna Sternjakob-Marthaler, Barbara Berkó-Göttel, Jürgen Rissland, et al.
EMBO Molecular Medicine
|
August 7, 2013
IgA EGFR antibodies mediate tumour killing in vivo
Peter Boross, Stefan Lohse, Maaike Nederend, et al.
Scientific Reports
|
September 27, 2024
The impact of the tumor microenvironment on the survival of penile cancer patients
Stefan Lohse, Jan Niklas Mink, Lea Eckhart, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 19, 2025
Evaluation of Nectin-4 and Trop-2: Implications for Patient Outcomes and Therapy in Penile Cancer
Jan Niklas Mink, Markus Eckstein, Oybek Khalmurzaev, et al.
Translational Oncology
|
November 13, 2021
DKK1 inhibits canonical Wnt signaling in human papillomavirus-positive penile cancer cells
Isabelle Ariane Bley, Anabel Zwick, Muriel Charlotte Hans, et al.
Frontiers in Oncology
|
October 28, 2022
The prominent role of the S100A8/S100A9-CD147 axis in the progression of penile cancer
Tobias Mohr, Anabel Zwick, Muriel Charlotte Hans, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 2, 2009
Human IgG2 antibodies against epidermal growth factor receptor effectively trigger antibody-dependent cellular cytotoxicity but, in contrast to IgG1, only by cells of myeloid lineage
Tanja Schneider-Merck, Jeroen J Lammerts van Bueren, Sven Berger, et al.
Cancer Research
|
December 5, 2015
An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In Vivo
Stefan Lohse, Saskia Meyer, Laura A P M Meulenbroek, et al.
Cancer Immunology Research
|
September 27, 2015
Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing
Arianne M Brandsma, Toine Ten Broeke, Maaike Nederend, et al.
Neoplasia (New York, N.Y.)
|
April 13, 2012
Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression
Stefanie Derer, Sven Berger, Martin Schlaeth, et al.
Plos One
|
September 2, 2022
Human papillomavirus vaccination of girls in the German model region Saarland: Insurance data-based analysis and identification of starting points for improving vaccination rates
Anna Sternjakob-Marthaler, Barbara Berkó-Göttel, Jürgen Rissland, et al.
EMBO Molecular Medicine
|
August 7, 2013
IgA EGFR antibodies mediate tumour killing in vivo
Peter Boross, Stefan Lohse, Maaike Nederend, et al.
Scientific Reports
|
September 27, 2024
The impact of the tumor microenvironment on the survival of penile cancer patients
Stefan Lohse, Jan Niklas Mink, Lea Eckhart, et al.
Page
of 5